Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 September 2020 | Story Andre Damons | Photo Supplied
Dr Martin Nyaga, Senior Lecturer and Researcher: NGS, will be heading the World Health Organisation Collaborating Centre (WHO CC).

The University of the Free State (UFS) has been designated a World Health Organisation Collaborating Centre (WHO CC), and the university’s Next Generation Sequencing (NGS) Unit, in partnership with the World Health Organisation (WHO), will for the next four years be conducting genome sequencing of pathogenic organisms, including rotavirus strains from the African continent. 

This centre will be part of the Vaccine Preventable Diseases (VPD) Pathogens Genomics Cluster and will run from September 2020 to September 2024. 

Dr Martin Nyaga, Senior Lecturer and Researcher: NGS/Virology, who will be heading the WHO CC, says an institution is designated as a WHO CC by the WHO Director-General and endorsed by the host country’s minister of health to form part of an international collaborative network, carrying out activities in support of the WHO programmess at all levels. A designation as a WHO CC is a time-limited agreement of collaboration between WHO and the designated institution, through which the latter agrees to implement a series of concrete activities, specifically designed for WHO.

A supreme achievement

Says Dr Nyaga: “In my opinion, a WHO CC designation is one of the supreme achievements an institution can be conferred as a recognition for foregoing exceptional collaborative venture with the WHO and showing future potential to assist the WHO with its global programmes and in our case, the WHO Regional Office for Africa region to offer solutions to the WHO VPD Surveillance and pathogens genomics cluster.”

According to Dr Nyaga this designation was awarded to the UFS after the WHO was content with the outcome of a service contract whereby the UFS-NGS unit undertook a pilot rotavirus surveillance project at whole genome level, using two African countries for the pilot, Rwanda and Zambia.

“From the outcomes of the pilot surveillance project between 2017 and 2019, the WHO/AFRO was satisfied with the genomic data that was generated and partially disseminated in scientific databases and journals as a collaborative venture. 

“It was thus proposed to strengthen its existing collaboration with the UFS-NGS Unit, which initiated the application process to designate the UFS-NGS unit as a WHO CC, an initiative that has taken approximately 20 months to finalise through the different phases of the application and approvals for the designation,” explains Dr Nyaga.

The purpose of the WHO CC

The new WHO CC will upon request by the WHO, implement agreed work plans in a timely manner and to the highest possible standards of quality and must comply with the referred terms of reference and conditions. These include: 
• Conducting genome sequencing of pathogenic organisms causing VPD, including rotavirus strains collected as part of the routine VPD surveillance using NGS technology and analysis of the generated datasets using bioinformatics tools.

• Conducting molecular characterisation of specimens collected during outbreaks and public health emergencies as part of the support for monitoring, preparedness and response to VPD disease outbreaks in Africa.

• Provide technical guidance to WHO on strategies to improve laboratory molecular diagnostics, molecular typing and NGS of rotavirus diarrheal strains and other enteropathogens to detect novel and re-emerging strains. 

• Conduct validation of tools and new molecular diagnostics for detection and characterisation of unusual or rare VPD strains to guide studies and development of new vaccines for VPD.

• Organise capacity-building and training workshops on whole genome sequencing of priority VPD pathogenic organisms.

The impact of the WHO CC on the work of the UFS-NGS 

According to Dr Nyaga, the designation brings extra responsibilities to his work and to the activities of the UFS-NGS unit. “Such initiatives are very welcome to enhance the business aspects, research and academic activities of the UFS-NGS unit, as the benefits are quite holistic since the collaboration enhances co-ownership of data and offers opportunities to train postgraduate students and other scientists.

“It also expands the research infrastructure and most importantly contributes to policy for numerous African governments in important decisions such as vaccine implementation activities, from an informed point of view and managing public health needs that require rapid response like outbreaks that may lead to pandemics.” 
• The current WHO CC designations at South African Institutions of higher learning and research can be found at: 

News Archive

UFS academic joins an elite league of achievers
2010-04-14

Prof. Dingie van Rensburg, Director of the Centre for Health Systems Research  Development at the University of the Free State
Prof. Dingie van Rensburg
Prof. Dingie van Rensburg, Director of the Centre for Health Systems Research & Development at the University of the Free State (UFS), has joined an elite list of a only few distinguished individuals who have been awarded honorary doctorates by the University of Antwerp (UA) in Belgium.

He is only the third South African to be honoured in this way by the UA, following in the footsteps of Constitutional Court Judge Albie Sachs (2000) and former State President, Nelson Mandela (2004).

He is the first social scientist from South Africa to receive this honorary doctorate from the UA – the highest academic distinction of that university. The university has previously only awarded three honorary doctorates to social scientists: Prof. Raymond Boudon, sociologist at the University of Paris-Sorbonne (1995); Prof. Robert Putman, political scientist at Harvard University (2000); and Prof. John Nash (of A Beautiful Mind fame), mathematician and economist at Massachusetts Institute of Technology (MIT) and Princeton.

The award ceremony will take place on 29 April 2010 in Antwerp.

Prof. Van Rensburg has authored, co-authored and was editor of many books/volumes, chapters in books, monographs, research reports and articles in scientific journals. He has also presented and co-presented at numerous national and international conferences; and supervised a significant number of master’s, doctoral and post-doctoral students.

In his 17 years as director of the Centre he has initiated, managed and led approximately 50 research and development projects, several of them large and long-term projects, and many of an inter-institutional and multidisciplinary nature.

In 2002 he became an NRF-rated researcher and in 2007 his rating as an established researcher was renewed. In the past two decades he received several research grants simultaneously from both the National Research Foundation and the Medical Research Foundation of South Africa, mostly for projects on Tuberculosis, HIV/Aids and antiretroviral treatment.

Prof Van Rensburg holds membership of both the Suid-Afrikaanse Akademie vir Wetenskap en Kuns and the Academy for Science of South Africa; he also served for varying periods on the Councils of both these academies. He was also a member of various health bodies of the Free State Province and the National Science and Technology Forum.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
14 April 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept